| Stage | BLDR | % of rev | HD | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $3.9B | 100.00% | $47.9B | 100.00% | HD ×12.42 |
| Gross profit | $1.1B | 27.82% | $16.1B | 33.67% | HD +5.8pp |
| Operating income | $99M | 2.57% | $6.8B | 14.29% | HD +11.7pp |
| Pre-tax income | $27M | 0.70% | $6.3B | 13.19% | HD +12.5pp |
| Net income | $60M | 1.57% | $4.8B | 9.96% | HD +8.4pp |
| Stage | BLDR | HD | Gap · A − B |
|---|---|---|---|
| Revenue | $3.9B100.00% | $47.9B100.00% | HD ×12.42 |
| Gross profit | 27.82%$1.1B | 33.67%$16.1B | HD +5.8pp |
| Operating income | 2.57%$99M | 14.29%$6.8B | HD +11.7pp |
| Pre-tax income | 0.70%$27M | 13.19%$6.3B | HD +12.5pp |
| Net income |
| 1.57%$60M |
| 9.96%$4.8B |
| HD +8.4pp |
None
No disclosed counterparties: BLDR.